Pres. Trump And COVID-19: Could Treatments Impact Brain Function?

The transcript discusses the use of supplemental oxygen in COVID-19 patients, highlighting the significance of oxygen level dips as indicators for hospitalization. It also covers a study showing that 82% of hospitalized COVID-19 patients experienced neurological issues, such as muscle pain and encephalopathy. The treatments for COVID-19, including dexamethasone, remdesivir, and polyclonal antibodies, are outlined, with a focus on their effectiveness and potential side effects. The transcript concludes with a note on the variability of patient reactions to these treatments.

What potential side effects of the treatments are mentioned in relation to neurological function?

How do individual reactions to medications vary according to the information provided?